Forminitrazole
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101660This classification denotes an antiprotozoal agent with the molecular formula C4H3N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GTW8DB3OVN, chemically known as formamide, n- (5-nitro-2-thiazolyl)- but generally known as forminitrazole, which bears US NIH Compound Identifier 219073. European Medicines Agency schedules Forminitrazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07786MIG. The term FORMINITRAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). FORMINITRAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule forminitrazole under HS 29341000 and SITC 51579. As of Q4 2014, FORMINITRAZOLE remains the US FDA Preferred Term for this commodity. Forminitrazole bears US NLM identifiers UMLS ID C1880843 and NCI Concept Code C65753. SMILES: S1C([N](=O)O)CNC1NC=O.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.